Queen's Awards Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

H3B-8800

SKU: orb1962246

Description

H3B-8800 is a small molecule modulator of SF3B1, a splicing factor. It serves as a research tool for investigating the underlying mechanisms of transfusion-dependent anemias, such as myelodysplastic syndromes, in both cellular and animal models.

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number1825302-42-8
MW555.71
Purity98.31%
FormulaC31H45N3O6
SMILESO(C(=O)N1CCN(C)CC1)[C@H]2/C=C/[C@H](C)[C@@H](\C(=C\C=C\[C@@H](C)C3=CC=CC=N3)\C)OC(=O)C[C@H](O)CC[C@@]2(C)O
TargetApoptosis,Others
SolubilityDMSO:122.5 mg/mL (220.44 mM)

Bioactivity

Target IC50
missense hotspot mutants R175H:8.3 nM|missense hotspot mutants R273H:3.2 nM|missense hotspot mutants R248H:16.3 nM|KPFLC cells (overexpressing human WT):26.5 nM|Panc05.04 cells:13 nM|SF3B1:0.3-2 nM
In Vivo
We conducted a Phase I clinical trial of H3B-8800, an oral small molecule compound that binds splicing factor 3B1 (SF3B1), in patients with MDS, CMML or AML. Of the 84 patients enrolled in the trial (42 MDS, 4 CMML and 38 AML), 62 were dependent on red blood cell (RBC) transfusions at enrollment. The dose-escalation cohort examined two once-daily dosing regimens: regimen I (5 days on/9 days off, study dose range 1-40 mg, n=65) and regimen II (21 days on/7 days off, 7-20 mg, n=19); 27 patients were treated for ≥180 days. The most common treatment-related emergent adverse events included diarrhea, nausea, fatigue, and vomiting. No complete or partial responses meeting IWG criteria were observed; however, RBC transfusion free intervals of more than 56 days were observed in nine patients who were transfusion dependent at enrollment (15%). Five of 15 MDS patients with missense SF3B1 mutations experienced RBC transfusion independence (TI). Increased expression of the pre-treatment target of splicing transmembrane protein 14C (TMEM14C) was observed in MDS patients experiencing RBC TI.

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

SF3B1, H3B 8800, H3B8800, H3B-8800

Similar Products

  • H3B-8800 [orb2655822]

    >98% (HPLC)

    1825302-42-8

    555.716

    C31H45N3O6

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

H3B-8800 (orb1962246)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 340.00
5 mg
$ 830.00
50 mg
$ 2,930.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry